Siemens Healthineers reports sales of 5,435 ME for the 2nd quarter of its 2024 fiscal year (i.e. Jan-Feb-March), up 1.7% on a reported basis and +3% on a comparable basis.

At the same time, adjusted EBIT rose by 8% to ME822, while net income came in at ME431, virtually quadrupling (+297%) compared with the same period a year earlier (ME108).

Adjusted EPS came to 0.55 euros, up 13%.

For fiscal 2024, Siemens Healthineers anticipates sales growth of between 4.5% and 6.5% compared with fiscal 2023, with adjusted EPS expected to be between 2.1 and 2.3 euros.

Copyright (c) 2024 CercleFinance.com. All rights reserved.